JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FNHC
3351
DELISTED
FedNat Holding Company Common Stock
FNHC
| $1.46M | ﹤0.01% |
88,002
-2,337
| -3% | -$34.6K |
2016 Q4
4 quarters
|
|
3352
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$692M
| $1.46M | ﹤0.01% |
31,265
+30,968
| +10,427% | +$1.41M |
2017 Q3
1 quarter
|
|
|
MTL
3353
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $1.46M | ﹤0.01% |
276,702
+29,333
| +12% | +$141K |
2015 Q4
8 quarters
|
|
|
RST
3354
DELISTED
ROSETTA STONE INC
RST
| $1.45M | ﹤0.01% |
116,407
+104,264
| +859% | +$1.16M |
2016 Q4
4 quarters
|
|
3355
CALL
Dollar Tree
DLTR
$21.5B
| $1.45M | ﹤0.01% |
+13,500
| New | +$1.32M |
2017 Q4
0 quarters
|
|
3356
iShares Expanded Tech-Software Sector ETF
IGV
$14.2B
| $1.45M | ﹤0.01% |
46,880
-2,605
| -5% | -$80.2K |
2015 Q4
8 quarters
|
|
3357
Investcorp Credit Management BDC
ICMB
$12M
| $1.45M | ﹤0.01% |
178,970
+36,359
| +25% | +$314K |
2015 Q4
8 quarters
|
|
3358
Azenta
AZTA
$1.51B
| $1.45M | ﹤0.01% |
60,561
+6,579
| +12% | +$187K |
2016 Q3
5 quarters
|
|
3359
Axcelis
ACLS
$4.22B
| $1.44M | ﹤0.01% |
50,183
+49,619
| +8,798% | +$1.56M |
2015 Q4
8 quarters
|
|
|
NRE
3360
DELISTED
NorthStar Realty Europe Corp.
NRE
| $1.44M | ﹤0.01% |
107,220
+39,907
| +59% | +$552K |
2015 Q4
8 quarters
|
|
|
FOLD
3361
CALL
DELISTED
Amicus Therapeutics
FOLD
| $1.44M | ﹤0.01% |
+100,000
| New | +$1.37M |
2017 Q4
0 quarters
|
|
|
FOLD
3362
PUT
DELISTED
Amicus Therapeutics
FOLD
| $1.44M | ﹤0.01% |
100,000
-36,000
| -26% | -$495K |
2017 Q3
1 quarter
|
|
3363
Vanguard Communication Services ETF
VOX
$5.75B
| $1.44M | ﹤0.01% |
15,781
+4,875
| +45% | +$438K |
2015 Q4
8 quarters
|
|
|
SDRL
3364
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
| $1.44M | ﹤0.01% |
23,222
-5,135
| -18% | -$409K |
2015 Q4
8 quarters
|
|
3365
Hecla Mining
HL
$11.4B
| $1.43M | ﹤0.01% |
360,233
-727,539
| -67% | -$3.16M |
2015 Q4
8 quarters
|
|
|
CTRA
3366
PUT
DELISTED
Coterra Energy
CTRA
| $1.43M | ﹤0.01% |
50,000
-110,000
| -69% | -$3.02M |
2017 Q3
1 quarter
|
|
|
FSB
3367
DELISTED
Franklin Financial Network, Inc.
FSB
| $1.43M | ﹤0.01% |
41,841
+341
| +0.8% | +$11.7K |
2015 Q2
10 quarters
|
|
3368
iShares ESG Optimized MSCI USA ETF
SUSA
$4.05B
| $1.43M | ﹤0.01% |
25,686
+19,756
| +333% | +$1.07M |
2015 Q4
8 quarters
|
|
|
AKS
3369
PUT
DELISTED
AK Steel Holding Corp
AKS
| $1.42M | ﹤0.01% |
+250,000
| New | +$1.3M |
2017 Q4
0 quarters
|
|
3370
CALL
Range Resources
RRC
$8.79B
| $1.41M | ﹤0.01% |
+82,800
| New | +$1.49M |
2017 Q4
0 quarters
|
|
|
VTLE
3371
DELISTED
Vital Energy
VTLE
| $1.41M | ﹤0.01% |
6,647
+6,022
| +964% | +$1.32M |
2013 Q2
18 quarters
|
|
3372
ATN International
ATNI
$432M
| $1.41M | ﹤0.01% |
25,485
-9,145
| -26% | -$500K |
2016 Q2
6 quarters
|
|
3373
AngioDynamics
ANGO
$636M
| $1.41M | ﹤0.01% |
84,620
-20,241
| -19% | -$345K |
2016 Q1
7 quarters
|
|
3374
Atlanta Braves Holdings Series A
BATRA
$3.71B
| $1.41M | ﹤0.01% |
63,847
-614
| -1% | -$14.4K |
2016 Q2
6 quarters
|
|
3375
CALL
Jack in the Box
JACK
$243M
| $1.4M | ﹤0.01% |
+14,300
| New | +$1.45M |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.